Bioidentical hormones are hormones that are chemically identical to the ones your body naturally produces. They include estradiol, progesterone, testosterone, and other steroid hormones, and they’re used primarily to treat symptoms of menopause, perimenopause, and other hormonal imbalances. Despite the name sounding high-tech, the term simply means the molecular structure of the hormone matches what your own cells already make and recognize.
How Bioidentical Hormones Are Made
Your body builds its hormones from cholesterol. Plants don’t make cholesterol, but they produce closely related compounds called plant sterols. To create bioidentical hormones, manufacturers extract these sterols (most commonly from soybeans or wild yams) and then chemically convert them in a lab through enzymatic processing until the final molecule is structurally identical to a human hormone. The starting material is “natural” in the sense that it comes from a plant, but the finished product is very much a product of chemistry. Bioidentical hormones can also be synthesized entirely from scratch in a lab or derived from animal sources.
This is worth understanding because marketing often emphasizes the plant origin to imply the hormones are gentler or safer. The plant source is just a raw ingredient. By the time it reaches your body, it has been transformed into a pharmaceutical product. Your hormone receptors can’t tell the difference between bioidentical estradiol and the estradiol your ovaries once made, which is the whole point.
The Three Bioidentical Estrogens
Humans naturally produce three main forms of estrogen, and bioidentical therapy can include any combination of them. They differ significantly in potency and behavior.
Estradiol (17β-estradiol) is the most active form. Before menopause, it’s the dominant estrogen in circulation and has the highest binding strength at both major estrogen receptor types. It is roughly 80 times more potent than estriol. Most FDA-approved bioidentical estrogen products contain estradiol.
Estrone becomes the predominant estrogen after menopause. It’s produced in fat tissue from estradiol and from a precursor made by the adrenal glands. It has moderate receptor activity and primarily binds to one of the two estrogen receptor types.
Estriol is the weakest of the three, with the lowest binding strength at either receptor. In nonpregnant women, blood levels are very low (around 10 picograms per milliliter), though the placenta produces it in large quantities during pregnancy. Unlike estrone, estriol does not convert back into estradiol in the body. It’s short-acting and is often included in compounded formulations, though its clinical benefits remain less well studied than estradiol’s.
Some compounding pharmacies offer “Bi-est” (a blend of estradiol and estriol) or “Tri-est” (all three). The rationale is that combining weaker estrogens with estradiol might reduce risk while still relieving symptoms, but this theory hasn’t been confirmed in large clinical trials.
FDA-Approved vs. Compounded
This is the distinction that matters most, and it’s where confusion runs deepest. Bioidentical hormones come in two very different forms.
FDA-approved bioidentical hormones are manufactured by pharmaceutical companies under strict federal oversight. They go through the same safety and efficacy testing as any other prescription drug. Examples include estradiol patches, gels, and pills, as well as micronized progesterone capsules. These are available at any standard pharmacy.
Compounded bioidentical hormones (cBHT) are custom-mixed by specialty compounding pharmacies, often based on a provider’s prescription tailored to an individual patient. These formulations are not subject to FDA monitoring for dose, purity, safety, or efficacy. No comprehensive clinical trial has examined the safety or efficacy of compounded bioidentical hormones for symptom relief, and no clinical outcomes trials have been completed.
The Endocrine Society has raised concerns that patients receive potentially misleading information about cBHT’s benefits and risks. The organization supports FDA regulation of all hormones regardless of how they’re made. Adverse events have been reported with compounded products, including cases of endometrial cancer and instances where blood hormone levels shot well above the anticipated range in women using compounded pellet therapy. Compounded formulations can also be inconsistent from batch to batch in dose and purity, a problem that regulated manufacturing processes are specifically designed to prevent.
Delivery Methods
Bioidentical hormones are available in several forms, and the route of delivery affects more than just convenience.
- Patches, creams, and gels (transdermal) deliver hormones through the skin directly into the bloodstream, bypassing the liver. This appears to lower the risk of blood clots compared to oral forms. Transdermal options tend to produce more modest symptom relief than some other routes, though they remain among the most commonly prescribed.
- Oral capsules and tablets pass through the digestive system and liver before entering circulation. They’re convenient but carry a somewhat higher risk of venous blood clots compared to transdermal delivery.
- Sublingual tablets dissolve under the tongue and are absorbed directly into the bloodstream. In observational studies, sublingual formulations were associated with greater reductions in hot flashes, anxiety, and sleep disturbance compared to topical forms.
- Pellets are small implants inserted under the skin, typically in the hip area, that release hormones over weeks to months. The delivery rate can be unpredictable. FDA adverse event data have documented cases of excessive hormone levels from compounded pellets, and pellet extrusions (where the implant pushes back out through the skin) have caused localized infections.
- Vaginal creams and inserts deliver hormones locally to treat vaginal dryness and urinary symptoms without raising whole-body hormone levels as much as systemic options.
Side Effects and Risks
Because bioidentical hormones are chemically identical to human hormones, they interact with the same receptors and carry the same general risks as any hormone therapy. Common side effects include weight gain, breast tenderness, bloating, headaches, mood swings, acne, spotting, and fatigue. Some people notice increased facial hair, particularly with testosterone-containing formulations. Patches, creams, and gels can cause local skin irritation, redness, or itching at the application site.
The more serious risks mirror those of conventional hormone therapy. Hormone use can increase the risk of blood clots, stroke, and gallbladder disease. The risk of heart disease and breast cancer may rise with extended use or when therapy is started well after menopause begins. People with a history of blood clotting disorders, cardiovascular disease, breast cancer, or stroke are generally not good candidates for any form of hormone therapy.
One persistent marketing claim is that bioidentical hormones are safer than conventional hormone therapy. Large-scale evidence does not support this. As Cleveland Clinic notes, no major research studies have demonstrated that bioidentical hormones carry fewer risks than their conventional counterparts. Compounded versions may actually carry more risk because their effects are less well studied and their formulations less standardized.
Hormone Testing and Monitoring
If you’re on bioidentical hormone therapy, your provider will likely monitor your hormone levels through blood tests. Blood is considered the most reliable body fluid for assessing systemic hormone levels.
Some compounding pharmacies and alternative practitioners promote saliva testing as a way to fine-tune hormone doses. While salivary cortisol testing does correlate reasonably well with blood levels, the relationship between saliva and blood varies widely depending on which hormone or biomarker is being measured. For many analytes, saliva levels do not reliably reflect what’s happening in circulation. Researchers have cautioned that saliva should not be casually substituted for blood, and the accuracy of the substitution needs to be verified for each specific hormone being tested.
What “Natural” Actually Means Here
The word “natural” is used heavily in bioidentical hormone marketing, but it doesn’t mean what most people assume. The hormones are synthesized in a lab from plant-derived raw materials. Conventional hormone therapies like conjugated equine estrogens (derived from horse urine) are also “natural” by the same logic. The meaningful difference between bioidentical and conventional hormones is molecular structure, not origin. Bioidentical hormones match human hormones molecule for molecule. Some conventional therapies contain hormone types not found in the human body, or mixtures of multiple estrogen compounds.
Whether that structural match translates into a meaningful clinical advantage is the central unresolved question. For FDA-approved bioidentical products like estradiol patches and micronized progesterone, there is solid evidence of safety and effectiveness from clinical trials. For compounded formulations, that evidence simply doesn’t exist yet at the same scale, which is why major medical organizations urge caution and recommend FDA-approved options when they can meet a patient’s needs.